Mpox Is Back in the News. Here's What Clinicians Need to Know

Africa faces a resurgent mpox outbreak, with the Democratic Republic of the Congo (DRC) at its epicenter. This crisis, marked by the spread of the deadlier clade I subtype and rising pediatric cases, poses significant global health challenges.

The DRC alone reports over 27,000 suspected cases and 1,300 deaths, yielding a 5% fatality rate. This evolving outbreak, characterized by high mortality and changing patient demographics, challenges existing disease control strategies.

Read More